Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine
- PMID: 29399577
- PMCID: PMC5795042
- DOI: 10.7774/cevr.2018.7.1.24
Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine
Abstract
Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic infection in wide range of intermediate hosts. Over one-third of the world's population are latently infected with T. gondii and carry it. The complex life cycle of T. gondii indicates the presence of a plurality of antigenic epitopes. During the recent years, continuous efforts of scientists have made precious advances to elucidate the different aspects of the cell and molecular biology of T. gondii. Despite of great progresses, the development of vaccine candidates for preventing of T. gondii infection in men and animals is still remains a challenge. The calcium-dependent protein kinases (CDPKs) belongs to the superfamily of kinases, which restricted to the apicomplexans, ciliates, and plants. It has been documented that they contribute several functions in the life cycle of T. gondii such as gliding motility, cell invasion, and egress as well as some other critical developmental processes. In current paper, we reviewed the recent progress concerning the development of CDPK-based vaccines against acute and chronic T. gondii.
Keywords: Adjuvant; Calcium-dependent protein kinase; Immunization; Toxoplasma gondii; Vaccines.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures

Similar articles
-
Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii.EXCLI J. 2019 May 21;18:259-272. doi: 10.17179/excli2018-1993. eCollection 2019. EXCLI J. 2019. PMID: 31337999 Free PMC article. Review.
-
Rhoptry antigens as Toxoplasma gondii vaccine target.Clin Exp Vaccine Res. 2019 Jan;8(1):4-26. doi: 10.7774/cevr.2019.8.1.4. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775347 Free PMC article. Review.
-
Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa.Mol Biol Evol. 2006 Aug;23(8):1613-27. doi: 10.1093/molbev/msl026. Epub 2006 Jun 2. Mol Biol Evol. 2006. PMID: 16751258
-
Vaccination with recombinant Toxoplasma gondii CDPK3 induces protective immunity against experimental toxoplasmosis.Acta Trop. 2019 Nov;199:105148. doi: 10.1016/j.actatropica.2019.105148. Epub 2019 Aug 16. Acta Trop. 2019. PMID: 31425673
-
Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.Parasitol Res. 2016 Feb;115(2):697-702. doi: 10.1007/s00436-015-4791-6. Parasitol Res. 2016. PMID: 26499803
Cited by
-
Recent progress in microneme-based vaccines development against Toxoplasma gondii.Clin Exp Vaccine Res. 2018 Jul;7(2):93-103. doi: 10.7774/cevr.2018.7.2.93. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112348 Free PMC article. Review.
-
Characterization of CpCaM, a protein potentially involved in the growth of Cryptosporidium parvum.Parasitol Res. 2023 Apr;122(4):989-996. doi: 10.1007/s00436-023-07803-9. Epub 2023 Mar 7. Parasitol Res. 2023. PMID: 36879147
-
Effective factors in the pathogenesis of Toxoplasmagondii.Heliyon. 2024 May 19;10(10):e31558. doi: 10.1016/j.heliyon.2024.e31558. eCollection 2024 May 30. Heliyon. 2024. PMID: 38818168 Free PMC article. Review.
-
Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Ameliorate Murine Chronic Toxoplasmosis.Pharmaceuticals (Basel). 2024 Jan 15;17(1):113. doi: 10.3390/ph17010113. Pharmaceuticals (Basel). 2024. PMID: 38256946 Free PMC article.
-
Rhomboid antigens are promising targets in the vaccine development against Toxoplasma gondii.EXCLI J. 2019 May 21;18:259-272. doi: 10.17179/excli2018-1993. eCollection 2019. EXCLI J. 2019. PMID: 31337999 Free PMC article. Review.
References
-
- Nasiri V, Teymurzadeh S, Karimi G, Nasiri M. Molecular detection of Toxoplasma gondii in snakes. Exp Parasitol. 2016;169:102–106. - PubMed
-
- Dubey JP. The history of Toxoplasma gondii: the first 100 years. J Eukaryot Microbiol. 2008;55:467–475. - PubMed
-
- Foroutan M, Dalvand S, Daryani A, et al. Rolling up the pieces of a puzzle: a systematic review and meta-analysis of the prevalence of toxoplasmosis in Iran. Alex J Med. 2017 Jun 23; doi: 10.4132/10.1016/j.ajme.2017.06.003. - DOI
-
- Rostami A, Riahi SM, Fakhri Y, et al. The global seroprevalence of Toxoplasma gondii among wild boars: a systematic review and meta-analysis. Vet Parasitol. 2017;244:12–20. - PubMed
-
- Khademvatan S, Foroutan M, Hazrati-Tappeh K, et al. Toxoplasmosis in rodents: a systematic review and meta-analysis in Iran. J Infect Public Health. 2017;10:487–493. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources